Praxis Precision Medicines (PRAX) Misses Q4 EPS by 41c
Tweet
Share
E-mailGet Alerts PRAX Hot Sheet
Join SI Premium – FREE
Praxis Precision Medicines (NASDAQ: PRAX) reported Q4 EPS of ($3.50), $0.41 worse than the analyst estimate of ($3.09).
For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mosaic (MOS), Others Lower Following Trump Post on Potash from Belarus
- Credo Technology shares rise on analyst support and conference comments
- US-China AI Deal To Open 'Hotline' For Communication - Fox Biz
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
